August 27, 2024 10:28 AM EDTUpdated 01:25 PM
Financing
Startups
Cell/Gene Tx

For­mer Re­genxbio lead­ers take rare dis­ease gene ther­a­pies to start­up with $15M

Lei Lei Wu

News Reporter

Two Re­genxbio gene ther­a­pies are get­ting a sec­ond chance at new­ly-seed­ed start­up Tern Ther­a­peu­tics, which launched from stealth Tues­day with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

SEC probe of Il­lu­mi­na’s Grail deal tar­gets sales fore­casts, sources say

Ar­bor Biotech­nolo­gies cuts ear­ly-stage dis­cov­ery work, lays off staff

Post-Hoc: Big promis­es built Mod­er­na. They might al­so be its un­do­ing

Af­ter a huge IPO and ac­qui­si­tion, Zymer­gen caps off bank­rupt­cy with $30M SEC penal­ty

FDA ap­proves sub­cu­ta­neous Ocre­vus, broad­en­ing ac­cess to Roche and Genen­tech block­buster

Doug Williams re­turns with a ‘FIT’ bet on CAR-Ts; Bio­gen ap­points Mene Pan­ga­los to board

A service from the Financial Times